baber/WOPTO huggingface dataset:
Patent JP-2000508649-A (JP)
Title: 速崩解性経口剤形物
IPC: A61K47/26
Filed: 1997-04-04
Abstract: (57)【要約】
本発明は、経口投与用の固形薬学的剤形物に関与し、それを口に入れると直ちに崩解する。さらに、本発明は、当該固形経口薬学的剤形物の製造において、都合がよく、費用のかからない方法に関与する。
Patent JP-2001513784-A (JP)
Title: アルキルヒドロキシメチルホスフィン酸のアルミニウム塩
IPC: C07F9/30
Filed: 1998-02-19
Abstract: (57)【要約】
１１０℃〜２５０℃において、加圧下、水中で、亜ホスホン酸を、水酸化アルミニウム又はパラホルムアルデヒド又はトリオキサン又はそれらの混合物と反応させることによって、アルキルヒドロキシメチルホスフィン酸のアルミニウム塩を調製する。生成したホスフィン酸アルミニウムは、ポリマー中、特にポリエステル中に練込まれ、その中で難燃作用を有する。
Patent JP-2001514815-A (JP)
IPC: G06F3/0489
Filed: 1998-03-12
Abstract: The invention relates to an input device with keys to which different functions are allocated, and with a display screen upon which the functions allocated to said keys are indicated. According to the invention, the keys are configured as swiveling keys to which one or two functions are allocated in each case. When two functions are allocated to one swiveling key, icons appear on the display screen. When one single function is allocated to a swiveling key, a text appears on the display screen indicating said function.
Patent JP-2000510253-A (JP)
IPC: G03F7/004
Filed: 1997-05-03
Abstract: A lithographic method for the generation of nanostructures on surfaces, characterized in that either stabilized nanometer-sized transition metal clusters or colloids of metals of groups 4, 5, 6, 7, 8, 9, 10, 11 or 12 of the Periodic Table, their stabilized metal oxide or metal sulfide analogues, polynuclear metal carbonyl clusters having stoichiometrically defined compositions, or polynuclear metal clusters having stoichiometrically defined compositions or having bridges consisting of main group elements, respectively in the form of a solution, are coated on a surface as a film which is imagewise exposed with an electron beam, wherein defined structures in the nanometer range are generated on the surface after washing off the unexposed portions of the film, optionally followed by annealing.
Patent JP-2001514784-A (JP)
Title: メモリとテスト回路とを備えた集積回路
IPC: G11C29/00
Filed: 1998-02-17
Abstract: (57)【要約】
メモリ２は、テスト回路３によってテスト可能であり、かつこのテスト回路３に、データ線路Ｄ１，Ｄ２、アドレス線路ＡＤＲ、および制御線路ＲＡＳ，ＣＡＳ，ＯＥを介して接続されている。これら線路のうち少なくとも１つは、スイッチ手段を経由して案内されている。スイッチ手段Ｌ，Ｇは、集積回路１の外部端子６，７を介して制御可能であり、これによって相応の線路の信号経過と、ひいてはテストの時間経過とを外部から制御することができる。本発明は、例えば組み込み式メモリコアの自己テストを実現するために好適である。
Patent JP-2000510362-A (JP)
Title: 内視鏡的画像法と内視鏡手術のためのシステム及び方法
IPC: A61B19/00
Filed: 1997-05-02
Abstract: (57)【要約】
ビデオ内視鏡、内視鏡手術器具、内視鏡と内視鏡手術器具とを一体に組み合わせるための保持部、または内視鏡や手術器具を挿通して体内に挿入するためのカニューレといったビデオ内視鏡手術の構成要素に対してビデオ画像ディスプレイが取り付けられる。取り付けは取付け機構により行われるが、取り付け機構は取り付けられる構成要素に応じてディスプレイの位置を変化させるために調整することが可能である。別の一実施例においては、長いチューブ状の形態を有する保持部を使用して、内視鏡と内視鏡手術器具とを一体に組み合わせて連動させる。内視鏡及び内視鏡手術器具は、直接に、またはカニューレを通じて体内に同時に挿入することが可能であり、術者が内視鏡と手術器具の両方を片手で操作することが可能である。内視鏡または保持部に取り付けられ、手術器具の作動ハンドルの付近に配置されたビデオディスプレイにより、術者に開放性手術の場合と同様の視覚感覚が提供される。
Patent JP-2001519102-A (JP)
Title: 単方向遠隔計測システム
IPC: H04L1/08
Filed: 1998-03-30
Abstract: (57)【要約】
遠隔計測システムは複数のビーコンを含む。各ビーコンは第１の予め決められた時間を有するパケットを繰り返し送信する。ビーコンは第１の所定の反復数だけパケットを送信する。モニタ受信機は複数のタイムスロットの各々で送信されたパケットを監視する。各スロットは第２の所定の持続時間を有する。第１の所定の持続時間は第２の所定の持続時間より短い。
Patent JP-2000511340-A (JP)
Title: 高い分解力でイオントラップ中のイオンを分離する方法及び装置
IPC: H01J49/42
Filed: 1997-05-19
Abstract: (57)【要約】
質量対電荷比の範囲を有する第１イオン群を分離するイオントラップ質量分析器の操作方法が開示されている。方法は複数の原子又は分子からイオンを生成し、トラッピング電圧をリング電極へ印加することによってイオンをトラッピングし、一対の端部キャップ電極へ励振電圧を印加し、励振電圧として第１、第２、第３励振部を有する広帯域励振波形であって、第１及び第３励振部は第１イオン群の殆んど全部と第１イオン群の少なくとも一種の質量対電荷比に略等しい質量対電荷比範囲を有する第２イオン群の殆んど全部とを除いてイオンを励振し、第１と第３励振部を印加して第１と第２イオン群の殆んど全部を除いたイオンを排出し、第２励振部を印加して第１イオン群の殆んど全部を除いたイオンを連続的に排出し、これによってイオントラップ中の第１イオン群を分離する。これに関連した装置も開示されている。
Patent JP-2001523414-A (JP)
Title: 無線通信装置用アンテナ
IPC: H01Q5/00
Filed: 1998-04-27
Abstract: (57)【要約】
この開示は、アンテナに関する。携帯電話においての送受信を改善するために、携帯電話は、いわゆるダイバシチーアンテナを備えている。本発明は、ダイバシチーアンテナとして好適なアンテナ（４）に関する。アンテナ（４）は、両面にホイル（１０、２２）を備えた絶縁材料製の板（２０）を備えている。ホイル（１０、２２）には、両側に１つずつ、２個のスロット（７、２３）が配されている。スロット（７、２３）は、その電気長が物理長よりも長くなるように、蛇行状構成又は巻回を備えている。一方のスロット（２３）は、他のスロットよりも１〜３％長い。一方のスロット（７）の閉止端（１２）には、給電用の配線のための接続部（１３、１４）がある。ホイル（１０、２２）は、担体（２０）の一側にこれと直角に強く半田付けされた板（１８）を介して互に接触している。スロット（７、２３）の長手方向に対して側面側に接地面（６）がある。ホイル（１０、２２）は、接地面（６）上に外方に延在し、互に電気的に接続（２７）されている。スロット（１５）は、接地面（６）の電気長を増大させるために、ホイル中に配されている。
Patent JP-2002505738-A (JP)
Title: プラスチックおよびその他の物質の帯電利用誘電運動検出器
IPC: G01V3/08
Filed: 1998-04-16
Abstract: (57)【要約】
誘電運動検出器は、外部帯電処理をした正確な誘電レプリカ基準物を収容する室を含む。基準物は機械的に拘束されており、これによって、基準物の誘電特性と同じ誘電特性を持つ目的物の存在を示唆する限定誘電泳動力の分極エネルギ変化パターンを検出することを可能にしている。アンテナアセンブリは検出の近接距離（領域）を増大させる。基準物用の帯電源は、連続検出能力を与えるための検出能力の寿命を増加させ、電流サージを介して電気エネルギの外部電子回路源は検出の定量可能な顕在化をもたらす。誘電泳動の原理にしたがって、検出器は、いかなる種類の介在視認障害物質構造・バリア・電磁障害（ＥＭＩ）信号の存否に関わりなく、特定の物質の存在を検出することができる。
Patent JP-2002502506-A (JP)
Title: 均質な多孔質材料の音響特性を予測かつ最適化するための方法
IPC: G06F19/00
Filed: 1998-05-15
Abstract: (57)【要約】
概して均質な多孔質材料の音響特性を予測するためのコンピュータ制御方法は、均質な多孔質材料の１つ以上の音響特性を決定するための少なくとも１つの予測モデルを設けるステップと、概して均質な多孔質材料の音響特性を予測する時に使用するために選択された予測モデルを設けるステップと、選択モデルに対応する少なくとも微細構造パラメータの入力組を設けるステップとを含む。均質な多孔質材料の１つ以上の巨視的性質は微細構造パラメータの入力組に基づき決定され、また均質な多孔質材料の音響特性は、１つ以上の巨視的性質および選択された予測モデルの関数として生成される。このような予測方法は、微細構造パラメータの入力組に基づき均質な柔らかい繊維質材料の流動抵抗率を予測するための流動抵抗率モデルを用いて、概して均質な柔らかい繊維質材料の音響特性を予測するために利用することが可能である。多数構成要素の音響システムの音響特性を予測するためにもう１つのコンピュータ制御方法が提供され、この方法は、音響システムの１つ以上の構成要素のために設けられる微細構造の入力に少なくとも部分的に基づき音響システムの音響特性を決定するための伝達行列プロセスを用いる。
Patent JP-2002505712-A (JP)
IPC: C08G65/20
Filed: 1999-04-15
Abstract: The present invention relates to a process for preparing hydroxyl-containing polymers, in particular for preparing polytetrahydrofuran with terminal hydroxyl groups, from the corresponding acyloxy-containing polymers by transesterification with alcohols in the presence of an alkali metal- or alkaline earth metal-containing catalyst, which entails the appropriate acyloxy-containing polymer being introduced together with the alcohol and the catalyst into a first prereactor (I) and converted therein at least partly to the hydroxyl-containing polymer, and the reaction solution being fed into the upper zone (IIa) of a distillation column (II) into whose lower zone (IIb) alcohol in vapor phase is additionally fed. This involves a phase exchange at the coherent and the disperse phase at the transition from the prereactor to the distillation column. Preferably, in addition to the first prereactor, a further 3 prereactors are used which serve as holdup reactors.
Patent MX-154904-A (MX)
Inventor: SCOBIE WILLIAM BRYCE
IPC: F16K1/226
Filed: 1983-01-31
Abstract: A seat ring for a rotary valve assembly comprising a radially inner seal section for sealing engagement with a valve element, a radially outer retaining section for mounting the seat ring in a valve body, and an intermediate spacer section interconnecting the sealing and retaining sections. The spacer section has a convoluted radial run, and the sealing section has a multiplicity of circumferential windings of strands in surrounding relation thereto.
Patent NZ-211484-A (NZ)
Title: Synergistic herbicidal compositions containing n-phosphomethylglycine derivative and pyrrolidine derivative
Inventor: GROENWOLD B E
IPC: A01N57/20
Filed: 1985-03-18
Abstract: Synergistic herbicidal activity is demonstrated by composition comprising aa mixture of (a) a trialkylsulfonium salt of N-phosphono-methylglycine having the formula (a) a herbicidally effective amount of a trialkylsulfonium salt of N-phosphonomethylglycine having the formula <CHEM> in which R is C1-C3 alkyl and n is 0 or 1, and (b) an herbicidally effective amount of a pyrrolidone compound of the formula X min  O <CHEM> in which X min  is hydrogen, chlorine or methyl; Y is hydrogen, chlorine, or bromine; Z is chlorine or bromine: R<1> is hydrogen, alkyl, acetyl, chlorine, bromine, fluorine, iodine, trifluoromethyl, nitro, cyano, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, pentafluoropropionamido or 3-methylureido; R<2> is hydrogen, alkyl, chlorine or trifluoromethyl; and R<3> is alkyl or hydrogen; in a pyrrolidone: N-phosphono-methylglycine weight ratio of from about 1:6 to about 4:1.
Patent NZ-214854-A (NZ)
Title: Oxidation resistant proteins with modified methione residues
Inventor: KOTHS K E
IPC: C12R1/91
Filed: 1986-01-17
Abstract: A biologically active reference (e.g. human) IL-2 (interleukin-2) protein is protected against oxidation by a method involving substituting a conservative amino acid for each methionine residue susceptible to chloramine T or peroxide oxidation and wherein additional, non-susceptible methionine residues are not so substituted.
Patent NZ-229423-A (NZ)
Title: Medicament comprising an essential fatty acid and vitamin e
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/20
Filed: 1989-06-06
Abstract: Method of, and preparations of medicaments for, treating schizophrenia and/or associated tardive dyskinesia by combining an essential fatty acid selected from GLA and higher n-6 series acids with an essential fatty acid selected from stearidonic acid and higher n-3 series acids in effective daily amounts of 10 mg and 50 g of each acid and with Vitamin E in addition.
Patent NZ-235106-A (NZ)
Title: Method for the immunological detection of analytes
Inventor: BAUMGARTEN HORST
IPC: G01N33/543
Filed: 1990-08-30
Abstract: For the detection of analytes with an immunological method by incubation with receptors and quantitation of complexes formed, at least one of the receptors used is a mixture of at least two monoclonal antibodies which are able to bind specifically to the analyte and which differ in cross-reactivity.
Patent NZ-288294-A (NZ)
Title: Tri-substituted phenyl derivatives; medicaments as phosphodiesterase (pde) type iv inhibitors
Inventor: WARRELLOW GRAHAM JOHN
IPC: A61P11/06
Filed: 1995-06-21
Abstract: Tri-substituted phenyl derivatives and processes for their preparation. In a preferred embodiment, the compounds have the general formula (1) wherein L may be -OR; Z may be -C(R3)(R4)-C(R5)(R6)(R7); R may be an optionally substituted cycloalkyl group; R3, R6 and R7 may be hydrogen; R4 may be -(CH2)t-Ar-(L1)n-Ar'; R5 may be -(CH2)tAr; Ar may be a monocyclic or bicyclic aryl or heteroaryl group; L1 may be a divalent linking group; and Ar' is Ar or an Ar containing group. Compounds of the invention may be potent and selective phosphodiesterase type IV inhibitors and are useful in the prophylaxis and treatment of various diseases, such as asthma, which are associated with an unwanted inflammatory response or muscular spasm.
Patent NZ-329481-A (NZ)
Title: Apparatus, for fabricating a stent, comprising a base for a flat sheet of metal and deforming means
Inventor: RICHTER JACOB
IPC: A61F2/06
Filed: 1997-12-23
Abstract: Apparatus for fabricating a stent comprises a base 401, a sheet receiving area 402 disposed on the base adapted to receive a flat sheet of metal to be formed into a stent, means, e.g. arm 403, for securing a mandrel 406 against a major surface of the flat sheet of metal, and means 407 for deforming the flat sheet of metal against the external surface of the mandrel so that the flat sheet of metal is deformed into a substantially tubular shape substantially conforming to the external surface of the mandrel with the long sides of the sheet of metal substantially parallel to each other.
Patent NZ-331525-A (NZ)
Title: Spring forming machine, two spring formers feed coils alternately to conveyor
Inventor: HAMILL STUART C
IPC: B21F35/00
Filed: 1998-08-24
Abstract: A coil spring forming and transfer machine includes two spring formers 113, 115.  Springs formed by the spring formers are passed by conveyers 321 to transfer conveyer 121.  The transfer conveyor is an endless conveyor that is moved intermittently to transfer springs to an assembly device, and is actuated by a servo motor.  The springs are transferred one at a time to the conveyor while the conveyor is stopped.  A control system automatically and non-selectively activates the conveyor servo-motor on the completion of a forming cycle of one of the spring formers.  When the conveyor movement has been completed, the control system automatically and non-selectively activates one of the spring formers.
Patent NZ-334729-A (NZ)
Title: 'Beta'-sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors involved in tissue degradation
Inventor: WARPEHOSKI MARTHA A
IPC: C07D233/72
Filed: 1997-09-19
Abstract: A compound of formula I or pharmaceutical acceptable salts thereof wherein: R1 is a) alkyl, b) alkenyl, c) alkynyl, d) -(CH2)h-(C3-8 cycloalkyl), e) -(CH2)h-aryl, f) -(CH2)h-aryl substituted with alkyl, alkoxy, halo, -N02, -CF3, -CN, or -N(alkyl)2, g) -(CH2)h-het, or h) -(CH2)h-het substituted with alkyl, or halo; R2 is a) alkyl, b) alkyl substituted with one to three halo, -CN, -NO2, -CF3, -N(R3)2, -SR3, or OH, c) alkenyl, d) alkenyl substituted with one to three halo, -CN, -N02, or -CF3, e) alkynyl, f) alkynyl substituted with one to three halo, -CN, -NO2, or -CF3, g) -(CH2)h-(C3-8 cycloalkyl), h) -(CH2)h-(C3-8 cycloalkyl) substituted with one to three alkyl, alkoxy, or halo, i) -(CH2)h-C3-8 cycloalkenyl, j) -(CH2)h-C3-8 cycloalkenyl substituted with one to three alkyl, alkoxy, or halo, k) -(CH2)h-aryl, l) -(CH2)h-aryl substituted with one to three alkyl, alkoxy, -CF3 -OH, -NO2, -CN, -N(R3)2, -SR3,-SO2(alkoxy), -C(=O)R3, or NC(=O)R3, m) -(CH2)h-aryl substituted with one to five halogen, n) -(CH2)h-het, o) -(CH2)h-het substituted with one to two alkyl, or halo, p) -(CH2)h-Q, q) -(CH2)h-Q substituted with one to three alkyl, alkoxy, halo or phenyl, r) -(CH2)i-X-R4, optionally the -(CH2)i- chain can be substituted with alkyl or phenyl, which in turn can be substituted with one to three halo or C 1-4 alkyl, or s) -(CH2)iCHR5R6; R3 is a) H, b) alkyl, c) -(CH2)h-phenyl, or d) -(CH2)h-phenyl substituted with one to three alkyl, alkoxy, or halo; X is   a) -O-, b) -S(=O)j- c) -NR7-, d) -S(=O)2NR8-, or e) R4 is a) H, b) alkyl, c) -(CH2)h-phenyl, d) -(CH2)h-phenyl substituted with one to three alkyl, alkoxy, halo, -NO2, or -CN, or e) -(CH2)h-het; R5 is a) alkyl, or b) -C(=O)R3; R6 is a) -C(=O)R3, or b) -(CH2)hC(=O)R3; R7 is a) H, b) alkyl, c) -(CH2)-phenyl, d) -(CH2)h-phenyl substituted with one to three alkyl, alkoxy, or halo, e) -C(=O)-R3, f) -S(=O)2R3, or g) -C(=O)OR3; R8 is a) alkyl, b) -(CH2)h-phenyl, or c) -(CH2)h-phenyl substituted with one to three alkyl, alkoxy, or halo; aryl is monocarbocyclic, or bicarbocyclic aromatic moiety; het is 5- to 10-membered unsaturated heterocyclic moiety having one to three atoms selected from the group consisting of oxygen, nitrogen, and sulfur; Q is 5- to 10-membered saturated heterocyclic moiety having one to two atoms selected from the group consisting of oxygen, nitrogen, and sulfur; h is 0,1, 2, 3, 4, 5, or 6; i is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; and j is 0, 1, or 2. These compounds are useful in the inhibition of matrix metalloproteinases.
Patent NZ-336147-A (NZ)
Title: Mycobacterium vaccae for down-regulation of the th2 activity without affecting (or up-regulation of) th1 activity
Inventor: ROOK GRAHAM ARTHUR WILLIAM
IPC: A61K35/74
Filed: 1997-12-17
Abstract: Antigenic and/or immunogenic material derived from Mycobacterium vaccae is used to down-regulate Th2 activity of the immune system without up-regulation of Th1 activity. Disorders such as Chronic Fatigue Syndrome, Gulf War Syndrome and Total Allergy Syndrome are treated. The material preferably comprises dead M. vaccae cells in a composition which does not include a non-M. vaccae antigen, immunogen or allergen.
Patent NZ-500940-A (NZ)
Title: Tilting stand, for a bulk container, comprising a lifting cylinder and a one way pressure valve connected to an input of the cylinder
Inventor: BOTTCHER ROBERT GREGORY
IPC: B65G65/23
Filed: 1999-11-11
Abstract: A tilting stand 10, for an intermediate bulk container, has a forward end defined by the direction of discharge, a rigid frame 11 supported above ground level, opposing pivots 13 extending from an upper deck 101 of the frame to a container support 12, a lifting cylinder 14 extending between the frame and the container support, and a one way pressure valve 17 connected to an input of the lifting cylinder for maintaining a constant, pre-established minimum pressure to the lifting cylinder so that the lifting cylinder acts like a spring.  The upper deck may be supported above a lower deck 102 by legs 103.  The stand may comprise a mechanical safety stop 70 which creates a limit between the frame and the container support and thus a minimum safe clearance between the frame and the container support.
Patent NZ-502526-A (NZ)
Title: Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
Inventor: TRASCIATTI SILVIA
IPC: C07K16/18
Filed: 1998-07-27
Abstract: Described are catalytic monoclonal antibodies (abzymes) for the in vivo transformation of corticosteroid prodrugs.  These abzymes are used in emergency therapy of acute adrenal insufficiency allowing a prompt pharmacological action of the corticosteroid.  Also described are haptens against which the abzymes are generated.
Patent NZ-505851-A (NZ)
Title: Foliar feed comprising 2 parts that are mixed just prior to application
Inventor: PONS ALEXANDER LEENDERT FRANK
IPC: C05G3/60
Filed: 1998-12-18
Abstract: A foliar feed comprising 2 parts to be mixed and diluted just prior to application is disclosed. The first part comprises a mix of urea and calcium chloride in water, and the second comprised a mixture of a liquid fertilizer, at lease one trace element and a pH adjusting and buffering agent. Once mixed and diluted, the solution is applied by spraying onto the leaves. Additionally, a fungicide or pesticide may be added once the two parts are combined.
Patent NZ-508582-A (NZ)
Title: Wastewater treatment process
Inventor: GAPES DANIEL JAMES
IPC: C02F3/12
Filed: 1999-06-04
Abstract: A biological wastewater treatment process wherein a controlled environment is provided for the encouragement of nitrogen-fixing microorganisms is described. The controlled environment is provided through the supply of a nitrogen- deficient feed and maintenance of a substantially stable dissolved oxygen level in the controlled environment. Also disclosed is biomass derived from wastewater treatment process.
Patent NZ-513838-A (NZ)
Title: Novel compounds
Inventor: BRUCK CLAUDINE ELVIRE MARIE
IPC: A61K48/00
Filed: 2000-03-09
Abstract: CASB618 polypeptides and CASB618 polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilising CASB618 polypeptides and CASB618 polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
Patent NZ-516498-A (NZ)
Title: Segmental retaining wall system
Inventor: BORGERSEN SVENN
IPC: E02D17/18
Filed: 2000-01-27
Abstract: Described is a wall block for use in a segmental retaining wall system.  The wall block comprises: i) An interior block face for forming an interior surface of a segmental retaining wall. ii) An exterior block face for forming an exterior surface of a segmental retaining wall. iii) First and second sides that extend from the exterior block face to the interior block face. iv) A top surface and a bottom surface v) A channel defined by a front wall, a rear wall, and an arcuate bottom surface, the channel extending across one of the faces and surfaces, the rear wall including an inwardly extending shoulder. vi) A flange that is sized and configured so as to mate with a channel of another of the blocks.  FIG.1 illustrates the concept of the described wall block as it relates to a wall block for use in a segmental retaining wall system (10). The wall block (12) comprises an interior face (26) for forming an interior surface of a segmental retaining wall, an exterior face (24) for forming an exterior surface of the segmental retaining wall, first and second sides (32) that extend from the exterior face to the interior face, and a top surface (28) and a bottom surface (30). Further provided in the wall block is a channel (16) defined by a front wall (36), a rear wall(38), and an arcuate bottom surface (40). The channel extends across one of the faces and surfaces
Patent NZ-518769-A (NZ)
Title: Foldable boats
Inventor: ROLFE DAVID WINDSOR
IPC: B63B7/04
Filed: 2000-10-09
Abstract: Bow and stern sections (1, 2) of a boat are hinged together to enable the bow section (1) to be folded over the stern section (2) which has wheels (6) deployed for towing and storage on land. The folded boat is towed by a towbar (10) bolted to a retracted spine (8) of a chassis (7) on which the stern section is mounted. The spine is extendable telescopically to support the unfolded bow section, and the wheels are pivotally-mounted on the chassis to be retracted by over-center operation, into open-bottom compartments (26) of the stern section; an interlock with the spine precludes wheel-retraction while the spine is retracted. Spring-biased doors (36) are freed to close the open-bottoms of the compartments in response to retraction of the wheels. The hinging of the bow and stern sections is via a panel (5) which is pivoted to both sections and which closes a gap between bulkheads (3, 4) in the folded boat and provides a seat over them when the bow section is unfolded.
Patent NZ-523416-A (NZ)
Title: Acid addition salts of hydropyridine derivatives
Inventor: ASAI FUMITOSHI
IPC: A61P9/10
Filed: 2001-07-03
Abstract: Acid addition salts of 2-acetoxy-5-(a-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine are disclosed. These acid addition salts exhibit excellent oral absorbability, metabolism-activating and platelet aggregation-inhibiting effects, low toxicity, and excellent storage and handling stabilities, and are useful as drugs, preferably preventive or therapeutic drugs (particularly therapeutic drugs) for diseases caused by thrombus or infarction, still preferably preventive or therapeutic drugs (particularly therapeutic drugs) for thrombosis or infarct.
Patent NZ-527408-A (NZ)
Title: Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
Inventor: GUIVARC H POL-HENRI
IPC: A61K31/365
Filed: 2001-04-20
Abstract: Described is an orally administered pharmaceutical composition for the treatment of elevated levels of cholesterol and related conditions comprising a statin and fenofibrate in the form of microparticles of solid fenofibrate that are stabilized by phospholipid as a surface active substance, wherein a therapeutically effective amount of the composition provides the statin and a quantity of fenofibrate to a fasted human patient that is greater than 80 % of the quantity of fenofibrate provided by the same amount of the composition when administered to the same patient who has been fed a high fat meal.
Patent NZ-528471-A (NZ)
Title: Retractable leg assembly
Inventor: BRYHAM MAURICE JOHN
IPC: B63C13/00
Filed: 2003-09-25
Abstract: Leg assembly (10) for an amphibious vehicle comprises leg (11) and linear actuator (33) each pivotally mounted, above the waterline, externally to hull (17). The linear actuator is pivotally mounted to the vehicle at or adjacent a point substantially midway along the length of the linear actuator when extended. The leg carries a wheel (13) which may be swivelled for steering using hydraulic linear actuator (15). The assembly is compact, light, yet capable of lifting the vehicle off the ground.